Is aggressive chemotherapy more effective in the treatment of plasma cell myeloma?
Bergsagel
D E
DE
University of Toronto, Ontario Cancer Institute, Canada.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis
D008558:Melphalan; D011241:Prednisone